NDC 51672-4083-07 - Hydrocortisone Butyrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4083
- Requested NDC
- 51672-4083-07
- Package NDCs from labels
- 51672-4083-5, 51672-4083-7, 51672-4083-1, 51672-4083-2, 51672-4083-6, 51672-4083-07
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Butyrate Ointment, 0.1% Hydrocortisone Butyrate Cream USP, 0.1% Hydrocortisone Butyrate Topical Solution, 0.1% | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4083-1 | Hydrocortisone Butyrate | 15 g in 1 TUBE | OINTMENT | 15 | 5 | |
| 51672-4083-1 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 30 g in 1 TUBE | OINTMENT | 30 | 5 | |
| 51672-4083-5 | Hydrocortisone Butyrate | 5 g in 1 TUBE | OINTMENT | 5 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 45 g in 1 TUBE | OINTMENT | 45 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 10 g in 1 TUBE | OINTMENT | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4083 | HYDROCORTISONE BUTYRATE SOLUTION HYDROCORTISONE BUTYRATE CREAM HYDROCORTISONE BUTYRATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 9 package rows | 20210409_51176835-598d-4da7-8a00-6bd36f52aa82.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4083-1 | GM - Gram | 51672-4083 | efb8d4d9-57f2-4954-890a-9738be50e6ed | 1 | 2012-07-24 |
| 51672-4083-6 | GM - Gram | 51672-4083 | 146e42f8-c9cd-4fa2-b41a-089bcca3cb99 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RUBBING ALCOHOL | ALCOHOL | INTERNATIONAL GENERAL TRADING CORP | bd5eb0df-cd2d-691c-e053-2995a90a2511 | 2024-12-18 | Warnings | ND2M416302 |
| Princess Petroleum | WHITE PETROLATUM | Ultra Distributors Inc. | 6d9c92bf-9263-40a4-acac-5c3f0b08c69d | 2024-12-18 | Warnings | 4T6H12BN9U |
| Isopropyl Rubbing Alcohol 70% | ISOPROPYL ALCOHOL | First Aid Research Corp. | 7d1c0382-31b3-48d0-a514-c5cc45a2299e | 2024-12-18 | Warnings | ND2M416302 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | 4T6H12BN9U T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | 4T6H12BN9U T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | 4T6H12BN9U T5L8T28FGP |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Meijer Petroleum Jelly | WHITE PETROLATUM | Meijer Distribution, Inc | b299cf2a-2c6a-68f4-e053-2995a90a5bd7 | 2024-12-18 | Warnings | 4T6H12BN9U |
| Caring Mills Petroleum Jelly | WHITE PETROLATUM | Veridian Healthcare | fbbfa780-0e2b-1874-e053-6394a90a5eeb | 2024-12-18 | Warnings | 4T6H12BN9U |
| TheraCare Petroleum Jelly | WHITE PETROLATUM | Veridian Healthcare | d6fad49b-8a49-7f7c-e053-2a95a90ae638 | 2024-12-18 | Warnings | 4T6H12BN9U |
| Global EASY PREP alcohol prep pads | ISOPROPYL ALCOHOL | Global Diabetic Distributors | a424b431-bf9c-4025-92a7-9d0b8a934c36 | 2024-12-18 | Warnings | ND2M416302 |
| OIDO SANA | ISOPROPYL ALCOHOL | ProMex LLC | 71e84695-49e8-459f-ac5e-118b5235fe06 | 2024-12-18 | Warnings | ND2M416302 |
| Jell Pharmaceuticals Vitamin A D | PETROLATUM | Jell Pharmaceuticals Pvt. Ltd. | 6ab8ba54-3679-4fd0-a876-cb89aace96ca | 2024-12-17 | Warnings | 4T6H12BN9U |
| Shea Butter Petroleum Jelly | PETROLATUM JELLY | Jell Pharmaceuticals Pvt. Ltd. | cd848f33-e863-d3af-e053-2a95a90a45b1 | 2024-12-17 | Warnings | 4T6H12BN9U |
| Equaline Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | United Natural Foods, Inc. dba UNFI | 739237a5-cc62-8ad6-e053-2991aa0a91f8 | 2024-12-17 | Warnings | XF417D3PSL |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | 4T6H12BN9U T5L8T28FGP |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | 4T6H12BN9U T5L8T28FGP |
| White Petrolatum | PETROLATUM | Geri-Care Pharmaceuticals, Corp | f40a29c2-65ea-91f9-e053-2a95a90ac439 | 2024-12-17 | Warnings | 4T6H12BN9U |
| Vitamin A and D | PETROLATUM | Geri-care Pharmaceutials Corp | fd76c101-a287-f92c-e053-6294a90a4468 | 2024-12-17 | Warnings | 4T6H12BN9U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.